84 related articles for article (PubMed ID: 23957649)
1. Assessing patients' perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: initial questionnaire development and validation.
Pettersson A; Turesson I; Persson C; Johansson B
Acta Oncol; 2014 Mar; 53(3):368-77. PubMed ID: 23957649
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy.
Pettersson A; Johansson B; Persson C; Berglund A; Turesson I
Radiother Oncol; 2012 Jun; 103(3):333-40. PubMed ID: 22633817
[TBL] [Abstract][Full Text] [Related]
4. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
van Andel G; Bottomley A; Fosså SD; Efficace F; Coens C; Guerif S; Kynaston H; Gontero P; Thalmann G; Akdas A; D'Haese S; Aaronson NK
Eur J Cancer; 2008 Nov; 44(16):2418-24. PubMed ID: 18774706
[TBL] [Abstract][Full Text] [Related]
5. Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity.
Reidunsdatter RJ; Lund JA; Fransson P; Widmark A; Fosså SD; Kaasa S
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):793-804. PubMed ID: 19879063
[TBL] [Abstract][Full Text] [Related]
6. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
[TBL] [Abstract][Full Text] [Related]
8. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
[TBL] [Abstract][Full Text] [Related]
9. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
10. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
11. Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire.
La Touche R; Pardo-Montero J; Gil-Martínez A; Paris-Alemany A; Angulo-Díaz-Parreño S; Suárez-Falcón JC; Lara-Lara M; Fernández-Carnero J
Pain Physician; 2014; 17(1):95-108. PubMed ID: 24452650
[TBL] [Abstract][Full Text] [Related]
12. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients.
Wan C; Tang X; Tu XM; Feng C; Messing S; Meng Q; Zhang X
Breast Cancer Res Treat; 2007 Oct; 105(2):187-93. PubMed ID: 17221159
[TBL] [Abstract][Full Text] [Related]
14. Development of a new chewing function questionnaire for assessment of a self-perceived chewing function.
Peršić S; Palac A; Bunjevac T; Celebić A
Community Dent Oral Epidemiol; 2013 Dec; 41(6):565-73. PubMed ID: 23551089
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia].
Richieri R; Boyer L; Reine G; Loundou AD; Simeoni MC; Auquier P; Lançon C
Encephale; 2011 Dec; 37(6):425-32. PubMed ID: 22137214
[TBL] [Abstract][Full Text] [Related]
16. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
Kontodimopoulos N; Ntinoulis K; Niakas D
Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
[TBL] [Abstract][Full Text] [Related]
17. Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report.
Goldner G; Wachter-Gerstner N; Wachter S; Dieckmann K; Janda M; Pötter R
Strahlenther Onkol; 2003 May; 179(5):320-7. PubMed ID: 12740659
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Pelvic Floor Distress Inventory-20 and the Pelvic Floor Impact Questionnaire-7 in Danish women with pelvic organ prolapse.
Due U; Brostrøm S; Lose G
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1041-8. PubMed ID: 23725572
[TBL] [Abstract][Full Text] [Related]
19. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
[TBL] [Abstract][Full Text] [Related]
20. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
